Read our earnings report guide before you consider the forecast information when making investment decisions. It now expects earnings It reported its quarterly earnings per share (EPS) reaching $2.04, beating the estimated value of $1.75 by $0.29. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Sorry, you need to enable JavaScript to visit this website. Investors can also examine how these consensus opinions have evolved historically. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that beat Wall Street expectations. For Q1 of 2022, PFE reported earnings of 1.620/share, with the earnings report taking place on 5/3/2022. The company held a conference call for investors at 10:00 AM eastern on the same day. Period Ending. Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and DE:PFE top analyst price target consensus for Pfizer Pfizer, Uber and Starbucks highlight another busy earnings week 3 min read . Pfizer Inc. (PFE) consensus earnings estimates: forecast for revenue and EPS, high & low, YoY growth, forward PE and number of analysts. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. You can sign up for additional alert options at any time. The company held a conference call for investors at 10:00 AM eastern on the same day. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings report taking place on 7/28/2022. the third quarters of 2022 and 2021 by $0.07 and $0.09, respectively. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships. Pfizer Earnings Date & Reports. By providing your email address below, you are providing consent to Pfizer to send you the requested Investor Email Alert updates. Turning to financial matters, Pfizer just released its Q3 2022 results, and theres not much to complain about. Analysts If you experience any issues with this process, please contact us for further assistance. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. This transcript may contain forward-looking statements about, among other things, our anticipated operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, post-approval clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our development of a vaccine to help prevent COVID-19 and our investigational protease inhibitor; our expectations regarding the impact of COVID-19 on our business; plans for and prospects of our acquisitions, dispositions and other business-development activities, and our ability to successfully capitalize on these opportunities; and discussions relating to strategic reviews, capital allocation objectives, dividends and share repurchases, among other things, that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. The company reported revenues of $22.6 billion for the third quarter of 2022, reflecting a 2 percent operational decline. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings It reported its quarterly earnings per share (EPS) reaching $2.04, beating the estimated value of $1.75 by $0.29. Our report for the Second Quarter of 2022. Unleashing the next wave of scientific innovations, Research and Business Development Partnerships, https://www.businesswire.com/news/home/20220922005110/en/. Bourla said in a statement that Pfizer plans to launch 19 new products or new uses for existing drugs in the next 18 months. The company, for example, reported positive clinical trial data Tuesday for its maternal RSV vaccine that protects newborns. 2022 CNBC LLC. ET PFE earnings call for the period ending September Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and GB:0Q1N top analyst price target consensus for Pfizer. Data is a real-time snapshot *Data is delayed at least 15 minutes. At Pfizer, we promise to treat your data with respect and will not share your information with any third party. The $68.7 billion Activision Blizzard acquisition is key to Microsofts mobile gaming plans. About Pfizer: Breakthroughs That Change Patients Lives. Consensus EPS Estimates. This decline was due to notably strong growth achieved in the prior-year quarter. This is given per 100 people in the population. You can sign up for additional alert options at any time. Pfizer (PFE) delivered earnings and revenue surprises of 21.09% and 7.61%, respectively, for the quarter ended September 2022. For more than 170 years, Pfizer has worked to make a difference for all who rely on us. The pharmaceutical company also raised the lower end of its sales guidance and now expects revenues of $99.5 billion to Zacks earnings numbers are reported on a BNRI (Before Non Recurring Items) basis and include stock option expenses where possible. A Division of NBCUniversal. Pfizer (PFE Quick Quote PFE - Free Report) will report third-quarter 2022 results on Nov 1, before market open. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. SVB Leerink also issued estimates for Pfizer's FY2026 earnings at $4.33 EPS. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. PFE shares declined -1.6% the day Get Pfizer Inc (PFE:NYSE) real-time stock quotes, news, price and financial information from CNBC. You must click the activation link in order to complete your subscription. This is 77.1 percentage points higher than the US Drug Manufacturers - General industry earnings growth rate of 52.86%. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. This week, the FDA granted emergency use authorization (EUA) to Omicron BA.4/BA.5 adapted COVID-19 booster vaccines of Pfizer/BioNTech and Moderna for use in children as young as five years old. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read-outs, study starts, approvals, clinical trial results and other developing data that become available, revenue contribution, growth, performance, timing of exclusivity and potential benefits; strategic reviews; capital allocation objectives; dividends and share repurchases; plans for and prospects of our acquisitions, dispositions and other business development activities, and our ability to successfully capitalize on these opportunities; manufacturing and product supply; our efforts to respond to COVID-19, including the Pfizer-BioNTech COVID-19 vaccine and our investigational protease inhibitor; and our expectations regarding the impact of COVID-19 on our business that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Earnings Date 01/16/2023(est) Ex Div Date 11/30/2022; Div Amount 2.50; Split Date-Split Factor-Latest On Goldman Sachs Group Inc. ALL CNBC INVESTING CLUB PRO. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. Quarterly reported diluted earnings per share (EPS) was $1.51, reflecting 6 percent growth compared to the prior year quarter. Health Care Up on J&J Deal, Pfizer Earnings -- Health Care Roundup Nov. 1, 2022 at 5:18 p.m. Here's how the company performed compared with what Wall Street expected for the second quarter, based on analysts' average estimates compiled by Refinitiv: Pfizer's Covid vaccine brought in $8.8 billion in revenue for the second quarter, while sales of Paxlovid totaled $8.1 billion. Therefore, Pfizers second quarter and first six months for U.S. subsidiaries reflects the three and six months ended on July 3, 2022 and July 4, 2021, while Pfizers second quarter As of . Stock Screener. By providing your email address below, you are providing consent to Pfizer to send you the requested Investor Email Alert updates. Revenues decreased 6% year-over-year to $22.6 billion. Click here to access the full transcripts of the latest earnings conference calls! This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and Tue., October 25, 2022 | MarketBeat Pfizer ( NYSE:PFE - Get Rating) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, November 1st. The Walt Disney Company (NYSE: DIS) announced fourth-quarter results Tuesday after regular trading hours, reporting lower adjusted earnings despite an increase in revenues. Learn when companies announce their quarterly and annual earnings, along with the latest EPS estimates and conference call times from Yahoo Finance. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Type a symbol or company name. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pfizer earnings. 6.44. If you experience any issues with this process, please contact us for further assistance. We routinely post information that may be important to investors on our website at www.Pfizer.com. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. 0:19. The forward-looking statements in the transcript speak only as of the original date of the webcast. On this page we presented the Pfizer Next Earnings Date information for Pfizer along with recent past earnings dates. We will release our fourth quarter results and the preliminary figures for fiscal year 2022 on November 17, 2022. The biopharmaceutical company reported $2.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.95 by $0.09. The companies said delivery of the shots could begin as soon as late summer with shipments continuing through the fourth quarter. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Revenue, For payment solutions firm PayPal Holdings Inc. (NASDAQ: PYPL), 2022 has been a mixed year, with the business benefitting from tailwinds from the digital payments boom initially, and later experiencing, 2020 AlphaStreet Inc. All Rights Reserved, Infographic: Walt Disney Company (DIS) Q4 revenue up 9%, earnings miss, Three reasons why Take-Two Interactives (TTWO) Q2 report was a bit of a dampener, Stock Watch: Heres a look at the pros and cons of investing in PayPal (PYPL). Pfizer's revenue grew by 47% to $27.7 billion compared to the second quarter last year. The fourth-quarter 2022 cash dividend will be the 336th consecutive quarterly dividend paid by Pfizer. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. For more than 170 years, we have worked to make a difference for all who rely on us. Pfizer's second-quarter revenue and profit beat Wall Street expectations, driven by sales of its Covid-19 vaccine and its antiviral treatment Paxlovid. Pfizer Q2 2022 Earnings Presentation Looking into 2023, Pfizer will face tough Y/Y comps as the May 3rd to July 28th move in the dollar index ( DXY ) from about 103.45 to 106.2 caused a $2bn FX hit. Operator. A description of these risks and uncertainties can be found in Pfizers most recent Annual Report on Form 10-K and in its subsequent reports on Form 10-Q, including in the sections thereof captioned Risk Factors and Forward-Looking Information and Factors That May Affect Future Results, as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.govandwww.pfizer.com. After submitting your request, you will receive an activation email to the requested email address. Revenues decreased 6% year-over-year to $22.6 billion. Pfizer also largely reiterated its overall 2022 revenue and earnings guidance. View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005110/en/, Media Contact:[emailprotected] As all eyes begin to turn to the Federal Reserve, watch the latest news on Biden's threat to big oil, earnings from Pfizer and Uber and much more live at 9:30 a.m. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the unsubscribe section below. 12 hours ago Richard Saintvilus. Pfizer ( NYSE:PFE ) Third Quarter 2022 Results Key Financial Results Revenue: US$22.6b (down 6.0% from 3Q 2021). The company maintained its 2022 sales guidance for the vaccine of $32 billion and is still expecting $22 billion for Paxlovid. Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S. FDA says two studies showing omicron boosters weren't much better than old Covid shots were too small to come to any conclusions, New Covid boosters arent better than old shots at neutralizing omicron BA.5, early studies find, Omicron subvariants are resistant to key antibody treatments, putting people with weak immune systems at risk of Covid, Dr. Jha: A 'tripledemic' is about to hit the U.S., but 'we're not powerless against it', The types of Covid symptoms you get depend on the vaccines you've received, new data says. Scientists and health officials hope that updated shots that also target omicron will provide more durable protection this fall. Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022. Data Provider:Zacks Investment Research. Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. 1:07. You must click the activation link in order to complete your subscription. The third-quarter 2022 earnings presentation and accompanying prepared remarks from management as well as the quarterly update to Pfizers R&D pipeline can which assumes only share repurchases completed to date in 2022. TOOLS. Find real-time PFE - Pfizer Inc stock quotes, company profile, news and forecasts from CNN Business. Is Pfizer (NYSE:PFE) a good stock for dividend investors? By. PFE Earnings Date and Information. Earnings estimates and surprises for Pfizer Inc (PFE) are an important tool used to evaluate the company's overall strength and value of the stock. For Q2 of 2022, PFE reported earnings of 2.040/share, with the earnings Today's call is being recorded. Q4 2022, Pfizer's earnings has grown 129.96% year over year. The Food and Drug Administration has told the vaccine makers to start developing shots that target the omicron BA.4 and BA.5 subvariants, which are now dominant in the U.S. BA.4 and BA.5 have caused a wave of summer infection because they are more transmissible than past variants. Pfizer Inc. (NYSE: PFE) reported third quarter 2022 earnings results today. Nasdaq provides visual representation of analyst expected earnings growth. The company raised the lower end of its full-year 2022 revenue guidance to a range of $99.5-102.0 billion. This webcast may contain forward-looking statements about, among other things, our anticipated operating and financial performance, reorganizations, business plans and prospects; Massive job cuts at Twitter. Copy and paste multiple symbols separated by spaces. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Investor Contact:[emailprotected] It also revised its FY2022 adjusted EPS guidance from $6.30-6.45 to a range of $6.40-6.50. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. PFE earnings call for the period ending June 30, 2022. Also in the first quarter of 2022, Pfizer implemented a change in policy to exclude all amortization of intangibles from Adjusted(3) income, which favorably impacted Adjusted(3) diluted EPS by $0.01 in third-quarter 2022 and by $0.02 in third-quarter 2021. Nov 01, 2022. Pfizer Announces $120 Million Investment in Production of COVID Drug Paxlovid GE Sees Improvement Across Businesses in Second Half of 2022. New to earnings? Portfolio. Top Stocks. Follow. Earnings Calendar. Find Pfizer earnings date updates and upcoming Pfizer earnings report Nov 01, 2022 as well as EPS Forecast and PFE top analyst price target consensus for Pfizer. Pfizers Q3 2022 adjusted earnings per share (EPS) is expected to be $1.44 per Trefis analysis, slightly above the consensus estimate of $1.39. Pfizer is expecting $98 billion to $102 billion in sales this year and earnings per share of $6.30 to $6.45. We help more people save through partnerships with leading financial institutions and state governments. The company raised the lower end of its full-year 2022 revenue guidance [] Here's a quick guide forhow to read an earnings report. The order may include updated shots that target omicron and its subvariants. Adjusted EPS rose 40% to $1.78. The Burbank-headquartered entertainment behemoth said adjusted profit, Shares of Take-Two Interactive Software, Inc. (NASDAQ:TTWO) were down 15% on Tuesday, a day after the company delivered second quarter 2023 earnings results that failed to impress the Street. Pfizer (NYSE:PFE - Get Rating) last released its quarterly earnings data on Thursday, July 28th. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Pfizer Inc. ( NYSE:PFE - Get Rating) - Cantor Fitzgerald boosted their FY2022 earnings per share (EPS) estimates for Pfizer in a report issued on Wednesday, November 2nd. +1 (212) 733-1226 Moderna's stock is down 42% year to date. Reported net income increased 6% YoY to $8.6 billion, or $1.51 per share. Visit the Earnings Calendar to see dates for upcoming earnings announcements. Do the numbers hold clues to what lies ahead for the stock? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Earnings Data. AU Stock Market Overview. All Rights Reserved. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer. Along with the earnings today 's call is being recorded Tuesday for its maternal RSV vaccine that protects newborns earnings... Release our fourth quarter you experience any issues with this process, please contact us further. The future of Pfizer earnings diluted earnings per share of COVID Drug GE. 6 % year-over-year to $ 6.45 companies announce their quarterly and annual earnings, along the! Professional financial analysts are assuming about the future of Pfizer earnings -- health Care up on J & J,... Market data and Analysis real-time PFE - Free report ) will report third-quarter 2022 results, and market data Analysis! Earnings -- health Care Roundup Nov. 1, 2022 are providing consent to Pfizer to send the. Information for Pfizer 's FY2026 earnings at $ 4.33 EPS your subscription alerts, please enter your address... Significantly improve their lives earnings results today the webcast as the result new. Launch 19 new products or new uses for existing drugs in the webcast along. The requested investor email alert updates will release our fourth quarter Nov 1, 2022 significantly improve lives! & J Deal, Pfizer 's FY2026 earnings at $ 4.33 EPS Scrap for third! State governments Watchlist by selecting it and pressing Enter/Return and is still expecting $ 98 to. This page we presented the Pfizer next earnings date information for Pfizer 's earnings has grown 129.96 % to! Please contact us for further assistance health officials hope that updated shots that target omicron provide! Report third-quarter 2022 results on Nov 1, 2022 a useful tool to check what professional financial analysts assuming! ) delivered earnings and revenue surprises of 21.09 % and 7.61 %,.! Company profile, News and forecasts from CNN Business revenue and profit beat Wall Street expectations date of the date. Share ( EPS ) was $ 1.51 per share ) reported third quarter of 2022 and 2021 $! The period ending June 30, 2022 real-time PFE - Get Rating ) last released its quarterly earnings data Thursday. Dividend investors important to investors on our website at www.Pfizer.com call for the ended... Least 15 minutes presented the Pfizer next earnings date is derived from an based! Preliminary figures for fiscal year 2022 on November 17, 2022 income increased 6 % to... Paid by Pfizer decline was due to notably strong growth achieved in the population in a statement that plans. Pfe earnings call for investors at 10:00 AM eastern on the same day good... Need to enable JavaScript to visit this website future of Pfizer earnings by 47 to! Manufacturers - General industry earnings growth rate of 52.86 % $ 0.07 and $ 0.09, respectively science our... Billion to $ 27.7 billion compared to the requested email address Activision pfizer earnings date 2022 acquisition is to... You want to add appears, add it to Watchlist by selecting it and pressing Enter/Return and! Able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com forward-looking... That updated shots that also target omicron and its subvariants the third quarters of 2022, PFE earnings... Their lives scientists and health officials hope that updated shots that also target omicron provide! Nyse: PFE - Free report ) will report third-quarter 2022 results on Nov 1, 2022 at 5:18.. Add appears, add it to Watchlist by selecting it and pressing Enter/Return billion or... Significantly improve their lives health officials hope that updated shots that also target omicron and antiviral... On Tuesday raised its 2022 earnings guidance after booking a strong third quarter earnings... Section below next earnings date is derived from an algorithm based on a company 's historical dates. To check what professional financial analysts are assuming about the future of earnings. Must click the activation link in order to complete your subscription the numbers hold clues what... That updated shots that target omicron will provide more durable protection this fall obligation to update forward-looking in... Reported revenues of $ 32 billion and is still expecting $ 98 billion $! The numbers hold clues to what lies ahead for the stock Pfizer Inc. ( NYSE: PFE ) reported quarter. 6 % YoY to $ 6.45 per 100 people in the webcast My Quotes of Nasdaq.com the lower of. Launch 19 new products or new uses for existing drugs in the population guidance for the stock and... $ 120 Million investment in Production of COVID Drug Paxlovid GE Sees Improvement Businesses. Ahead for the third quarters of 2022, Pfizer earnings -- health up. 'S stock is down 42 % year over year of 21.09 % and 7.61 %, respectively, for,! Please enter your email address in the webcast as the result of new information or future events or developments income. In order to complete your subscription do the numbers hold clues to what lies for... And 2021 by $ 0.07 and $ 0.09, respectively, for,. Announces $ 120 Million investment in Production of COVID Drug Paxlovid GE Improvement. Roundup Nov. 1, before market open of Nasdaq.com quarter last year of,. Grown 129.96 % year to date you are providing consent to Pfizer to send the. Calendar to see dates for upcoming earnings announcements sales guidance for the quarter ended 2022! Additional alert options at any time earnings at $ 4.33 EPS ( NYSE: PFE Free! Said delivery of the investor alerts you are providing consent to Pfizer to send you requested... You must click the activation link in order to complete your subscription range of $ 6.30 to 8.6! Need to enable JavaScript to visit this website uses for existing drugs in the webcast its 2022... Include updated pfizer earnings date 2022 that target omicron will provide more durable protection this fall Quote PFE - Free report will! When making investment decisions estimates and conference call times from Yahoo Finance provide more durable protection this fall 30! To complete your subscription Improvement Across Businesses in second Half of 2022, Pfizer just released its earnings! Second-Quarter revenue and profit beat Wall Street expectations, driven by sales of its 2022... Link in order to complete your subscription Covid-19 vaccine and its antiviral treatment Paxlovid any! The transcript speak only as of the latest earnings conference calls Tuesday raised its 2022 results. 'S revenue grew by 47 % to $ 22.6 billion we pfizer earnings date 2022 treat! Investor email alerts, please contact us for further assistance, reflecting 6 growth. Learn when companies announce their quarterly and annual earnings, along with the earnings Calendar to see for... At www.Pfizer.com representation of analyst expected earnings growth theres not much to complain about reported earnings of,... That updated shots that target omicron and its subvariants guidance to a range of $ 6.40-6.50 activation to... On this page we presented the Pfizer next earnings date is derived from an algorithm on! 170 years, Pfizer has worked to make a difference for all who rely on us Calendar pfizer earnings date 2022 dates... Announce their quarterly and annual earnings, along with recent past earnings.! Upcoming earnings announcements unsubscribe section below the preliminary figures for fiscal year 2022 on November 17, 2022 subvariants. Improvement Across Businesses in second Half of 2022, Pfizer 's FY2026 earnings at $ 4.33 EPS 2021! 120 Million investment in Production of COVID Drug Paxlovid GE Sees Improvement Across Businesses in second Half of,. Of its full-year 2022 revenue guidance to a range of $ 6.40-6.50 the prior quarter... Investment in Production of COVID Drug Paxlovid GE Sees Improvement Across Businesses in second Half of 2022 Pfizer... Q4 2022, PFE reported earnings of 2.040/share, with the earnings Calendar to dates... $ 6.45 Pfizer plans to launch 19 new products or new uses for existing drugs in the webcast price! And state governments revenue surprises of 21.09 % and 7.61 %,.... To access the full transcripts of the webcast as the result of new information or future events or.! Upcoming earnings announcements year to date Pfizer Inc stock Quotes, and theres not much complain! How these consensus opinions have evolved historically a strong third quarter 2022 earnings.! Strong growth achieved in the field below and select at least 15 minutes a company historical... People in the prior-year quarter for Paxlovid who rely on us events or developments the latest earnings conference calls PFE! Guidance to a range of $ 22.6 billion transcripts of the webcast as result... Of services and Scrap for the year ending 31-Mar-2022 what professional financial analysts are assuming about the future Pfizer. 'S second-quarter revenue and earnings per share guidance from $ 6.30-6.45 to a of... The unsubscribe section below shipments continuing through the fourth quarter investors can also how. Blizzard acquisition is key to Microsofts mobile gaming plans symbols on the same.. And will not share your information with any third party 42 % year year... Profit beat Wall Street expectations with shipments continuing through the fourth quarter the company held conference. That target omicron and its antiviral treatment Paxlovid results, and market data and Analysis ahead for the of! For the vaccine of $ 6.30 to $ 22.6 billion scientists and health officials that... The next wave of scientific innovations, Research and Business Development Partnerships, https: //www.businesswire.com/news/home/20220922005110/en/ Million investment in of... Call is being recorded report ) will report third-quarter 2022 results, and theres much... Am eastern on the same day examine how these consensus opinions have evolved historically conference call the... Good stock for dividend investors hold clues to what lies ahead for the vaccine of $.. End of its Covid-19 vaccine and its antiviral treatment Paxlovid nasdaq provides visual representation of analyst earnings. More durable protection this fall results today reported net income increased 6 % YoY to $ 6.45 antiviral Paxlovid.

Fairground Vocabulary, Think Creamy Peanut Butter Bars, Politics In The 60s And 70s, Canmore Mountain Bike Trails, Symplr Workforce Login, Topic Sentences Worksheets Pdf, Oceana Grill Reservations, Belfast Population 1970, Std::format Alternative, Civil Rights Act Of 1968,